Lifestyle Intervention for Sustained Remission of Metabolic Syndrome: A Randomized Clinical Trial.

ABSTRACT:

Importance

Prevalence of metabolic syndrome (MetS) defined as 3 or more cardiometabolic risk factors has grown to 43% among US adults. Lifestyle interventions produce benefits, but with limited sustainability.

Objective

To determine whether a 6-month habit-based lifestyle program adds benefit to education and activity monitoring for sustained MetS remission at 24 months.

Design, setting, and participants

The Enhancing Lifestyles in Metabolic Syndrome (ELM) study was a single-blind, individually randomized clinical trial of participants with MetS recruited from July 2019 to January 2022 at 5 locations in the US and followed up for 24 months. Eligible participants were motivated for lifestyle change and were contacted using electronic medical records and social or mass

SUBMITTER: Powell LH 

PROVIDER: S-EPMC12598583 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature